InsidersTradesSigma
Discover the detailed record of transactions filed by Schuyler Kevin, Director. Insider active across 1 companies, notably Adial Pharmaceuticals, INC.. Cumulatively, 2 reports have been logged. The latest transaction was filed on 23 December 2021 — Don. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Schuyler Kevin serves as a Board Member at Adial Pharmaceuticals, Inc. He plays a key role in the strategic direction of the company, bringing his expertise in the pharmaceutical field. As a board member, he is responsible for overseeing operations and evaluating the company's performance. Kevin is committed to supporting innovation and fostering sustainable growth within the organization.